TL;DR
This study investigated how pre-treatment hormone levels affect the prognosis of male HIV patients on antiretroviral therapy (ART). While most hormones showed no significant link to immunological failure, high cortisol levels emerged as a critical predictor of mortality, underscoring the complex interplay between endocrine function and HIV progression.
What Problem Does This Paper Address?
Human Immunodeficiency Virus (HIV) infection is known to disrupt various bodily systems, including the endocrine system. While antiretroviral therapy (ART) has dramatically improved outcomes, some patients still experience immunological failure (a decline in immune function despite treatment) or mortality. Previous research has hinted at endocrine abnormalities in HIV patients, but a clear understanding of how specific hormone levels at the start of ART influence long-term prognosis, particularly immunological failure and mortality, has been lacking. This paper aims to fill that gap by prospectively examining the correlation between baseline hormone levels and these critical clinical outcomes in a cohort of male HIV patients.
Methods
The researchers conducted a prospective follow-up study on 163 male HIV patients initiating ART between July 2011 and June 2014. They collected blood samples before ART initiation to measure seven key hormones: cortisol, ACTH, BNP, aldosterone, ADH, renin, and DHEA-S. Clinical data, including demographics, underlying conditions, and World Health Organization (WHO) clinical stage, were also gathered.
To analyze the data, they employed standard statistical methods:
- Kaplan-Meier method: Used to estimate survival and immunological failure probabilities over time.
- Multivariate Cox proportional hazard model: Employed to identify independent predictors of immunological failure and mortality, controlling for other factors.
- Pearson correlation: Used to assess the relationship between hormone concentrations and CD4+ T cell counts or HIV-RNA load.
- Student's t-test and Mann-Whitney U test: Used for comparing hormone levels between different groups (e.g., HIV patients vs. healthy controls, WHO stage 4 vs. other stages).
Datasets
The study utilized data from 163 male HIV patients recruited from the First Affiliated Hospital of China Medical University. A control group of 80 age-matched healthy male volunteers was also included for comparison of hormone levels. No new datasets were introduced.
Key Insights and Ideas
- Cortisol as a Mortality Marker: The most striking finding is that high baseline cortisol levels, even before ART, are a significant predictor of mortality in HIV patients. This suggests that the body's stress response, as reflected by cortisol, plays a crucial role in determining survival outcomes.
- Hormonal Independence from Immunological Failure: Surprisingly, none of the measured hormones showed a strong correlation with immunological failure. This implies that factors other than these specific hormonal imbalances are primarily driving the failure of ART to restore immune function.
- DHEA-S and Disease Severity: Dehydroepiandrosterone sulfate (DHEA-S) levels were strongly correlated with both CD4+ T cell counts and WHO clinical stage. Lower DHEA-S was associated with more advanced disease, aligning with its known role in immune function and stress response.
- Hyponatremia and Tuberculosis as Risk Factors: Beyond hormonal factors, hyponatremia (low sodium levels) and active tuberculosis were identified as significant risk factors for mortality, reinforcing the importance of managing co-infections and metabolic disturbances.
- WHO Stage 4 as a Key Predictor: Being at WHO clinical stage 4 was a significant predictor for both immunological failure and mortality, highlighting the critical role of overall disease severity in prognosis.
Key Results
- Mortality Rate: The study observed a mortality rate of 16.0% (26/163) among the HIV patients, with 84.6% of these deaths being AIDS-related.
- Immunological Failure Rate: 53 patients (32.5%) experienced immunological failure.
- Hormone Differences: HIV patients had significantly higher plasma cortisol, ACTH, BNP, and renin concentrations, and significantly lower DHEA-S levels compared to healthy controls.
- Mortality Predictors: Multivariate Cox regression identified high cortisol levels (≥52.0 µg/dL), hyponatremia (<135 mmol/L), active tuberculosis, and WHO clinical stage 4 as significant predictors of mortality.
- Immunological Failure Predictor: WHO clinical stage 4 was the only significant predictor of immunological failure (HR: 3.225; 95% CI, 1.687–6.165).
Limitations and Future Work
The authors acknowledge several limitations:
- No Post-ART Hormone Data: The study only measured hormone levels before ART, preventing an assessment of how ART itself might alter these hormonal profiles or their impact.
- Limited Hormone Panel: Not all potential endocrine markers were assessed (e.g., testosterone, thyroid function).
- Exclusion Criteria: The study excluded children, women, intravenous drug users, and former plasma donors, limiting generalizability.
Future work should focus on longitudinal studies to track hormonal changes during ART and their impact on outcomes. Further research is also needed to explore the mechanisms by which high cortisol contributes to mortality and to develop interventions for these endocrine abnormalities in HIV patients. The authors suggest that large longitudinal studies are needed to substantiate the importance of intervening in these subclinical abnormalities.
Summary updated